Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $1.7 billion.

  • Ptc Therapeutics' Cash & Current Investments rose 6655.7% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 6655.7%. This contributed to the annual value of $1.1 billion for FY2024, which is 2999.26% up from last year.
  • Latest data reveals that Ptc Therapeutics reported Cash & Current Investments of $1.7 billion as of Q3 2025, which was up 6655.7% from $2.0 billion recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Cash & Current Investments high stood at $2.0 billion for Q1 2025, and its period low was $286.3 million during Q1 2023.
  • Over the past 5 years, Ptc Therapeutics' median Cash & Current Investments value was $876.7 million (recorded in 2023), while the average stood at $894.8 million.
  • As far as peak fluctuations go, Ptc Therapeutics' Cash & Current Investments tumbled by 6676.83% in 2022, and later soared by 24373.22% in 2024.
  • Ptc Therapeutics' Cash & Current Investments (Quarter) stood at $773.4 million in 2021, then tumbled by 46.89% to $410.7 million in 2022, then skyrocketed by 113.47% to $876.7 million in 2023, then grew by 29.99% to $1.1 billion in 2024, then skyrocketed by 48.09% to $1.7 billion in 2025.
  • Its Cash & Current Investments was $1.7 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $2.0 billion in Q1 2025.